SBIO Holdings Information

SBIO is an equity ETF with a total of 86 individual holdings. The top holdings are Alkermes stock at 4.87%, Kymera Therapeutics at 4.16%, Spyre Therapeutics at 3.89%, Mirum Pharmaceuticals at 3.89%, and Apogee Therapeutics at 3.20%.

Total Holdings

Top 10 Percentage

34.44%

Asset Class

Equity

ETF Category

Health

Assets

148.98M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ALKS	Alkermes plc	4.87%	168,837
2	KYMR	Kymera Therapeutics, Inc.	4.16%	82,640
3	SYRE	Spyre Therapeutics, Inc.	3.89%	79,498
4	MIRM	Mirum Pharmaceuticals, Inc.	3.89%	61,055
5	APGE	Apogee Therapeutics, Inc.	3.20%	56,652
6	CGON	CG Oncology, Inc.	3.16%	85,470
7	TVTX	Travere Therapeutics, Inc.	2.99%	93,453
8	XENE	Xenon Pharmaceuticals Inc.	2.93%	84,206
9	CELC	Celcuity Inc.	2.78%	46,791
10	EWTX	Edgewise Therapeutics, Inc.	2.57%	108,518
11	ACAD	ACADIA Pharmaceuticals Inc.	2.55%	172,488
12	DNTH	Dianthus Therapeutics, Inc.	2.48%	44,969
13	NAMS	NewAmsterdam Pharma Company N.V.	2.45%	116,323
14	CRNX	Crinetics Pharmaceuticals, Inc.	2.42%	106,078
15	VKTX	Viking Therapeutics, Inc.	2.33%	117,107
16	ORKA	Oruka Therapeutics, Inc.	2.14%	49,058
17	DNLI	Denali Therapeutics Inc.	2.14%	160,721
18	IDYA	IDEAYA Biosciences, Inc.	1.91%	89,000
19	GPCR	Structure Therapeutics Inc.	1.84%	71,794
20	TARS	Tarsus Pharmaceuticals, Inc.	1.75%	43,134
21	IRON	Disc Medicine, Inc.	1.73%	38,674
22	RLAY	Relay Therapeutics, Inc.	1.68%	181,129
23	VERA	Vera Therapeutics, Inc.	1.56%	72,316
24	PHVS	Pharvaris N.V.	1.39%	64,916
25	CLDX	Celldex Therapeutics, Inc.	1.31%	67,463

Showing 25 of 86 holdings

Subscribe to see the full list

Activate Now

As of Jun 8, 2026